Pictet Asset Management’s Transmedics TMDX Stock Holding History

Pictet Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$523K	Buy	5,266 +408	+8%	+$53.2K	﹤0.01%	1433
2025 Q4	$591K	Buy	4,858 +382	+9%	+$47.9K	﹤0.01%	1355
2025 Q3	$502K	Hold	4,476	–	–	﹤0.01%	1380
2025 Q2	$600K	Buy	4,476 +42	+0.9%	+$4.61K	﹤0.01%	1275
2025 Q1	$298K	Hold	4,434	–	–	﹤0.01%	1621
2024 Q4	$276K	Sell	4,434 -274	-6%	-$25.5K	﹤0.01%	1688
2024 Q3	$740K	Buy	4,708 +562	+14%	+$86.6K	﹤0.01%	1178
2024 Q2	$624K	Hold	4,146	–	–	﹤0.01%	1182
2024 Q1	$307K	Hold	4,146	–	–	﹤0.01%	1532
2023 Q4	$327K	Hold	4,146	–	–	﹤0.01%	1493
2023 Q3	$227K	Buy	+4,146	New	+$298K	﹤0.01%	1627

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pictet Asset Management's TMDX Position: Q1 2026 in Review

Pictet Asset Management increased its Transmedics (TMDX) stake by 8.4% in Q1 2026, buying an estimated $53.2K and bringing the position to 5,266 shares worth $523K. The position accounts for ﹤0.01% of the portfolio, ranked #1433.

Pictet Asset Management first reported a position in TMDX in Q3 2023 and has held it in 11 quarters since. The position peaked at $740K in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Pictet Asset Management held 5,266 shares of Transmedics worth $523K as of Q1 2026.
Pictet Asset Management bought 408 Transmedics shares in Q1 2026, an estimated $53.2K.
Transmedics made up ﹤0.01% of Pictet Asset Management's portfolio in Q1 2026, its #1433 holding.
Pictet Asset Management first reported a position in Transmedics in Q3 2023 and has held it in 11 quarters since.
Pictet Asset Management's Transmedics position peaked at $740K in Q3 2024.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.